Prostate biopsy has shifted from systematic, non-targeted sampling towards imaging-directed approaches, but the extent to which systematic cores can be safely reduced remains uncertain. This review examines current evidence on contemporary biopsy strategies in men with suspected prostate cancer. A structured PubMed/MED...
G. Tsakaldimis, D. Diamantidis, S. Lailisidis et al.· Journal of Imaging· 0 citations
To evaluate whether restricting systematic biopsy to the ipsilateral side of a unilateral multiparametric magnetic resonance imaging (mpMRI) lesion, in combination with cognitive MRI-targeted biopsy, affects the detection of clinically significant prostate cancer (csPCa) in biopsy-naïve patients.
This retr...
G. Tsakaldimis, D. Diamantidis, Nikolaos Smyrlis et al.· BMC Urology· 0 citations
This narrative review synthesizes evidence across both cancers in imaging, digital pathology, molecular and liquid-biopsy data, and clinical applications and assesses deployment readiness and explains explainability without post hoc approximation.
D. Diamantidis, G. Tsakaldimis, Nikolaos Smyrlis et al.· Current Urology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.